, an analyst from TP ICAP MIDCAP, maintained the Buy rating on Abitare In SpA (ABT – Research Report). The associated price target was lowered to €6.20.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TP ICAP (Europe) S.A. has given its Buy rating due to a combination of factors that reflect both the current performance and future potential of Abitare In SpA. Despite revising their forecasts downward for 2025–2027, the firm maintains a positive outlook based on the company’s robust activity in the first half of 2025, which showed significant year-over-year growth in revenue. The stability in EBITDA and the anticipated reduction in net debt by March 2026 further support the Buy recommendation.
Additionally, TP ICAP (Europe) S.A. has adjusted its price target slightly to €6.2, reflecting a cautious yet optimistic stance pending regulatory developments in Milan. The focus on smaller-scale projects and the expectation of a gradual recovery in volume are seen as strategic moves that could enhance Abitare In’s market position. These factors collectively underpin the firm’s confidence in the stock’s potential, despite the slower-than-expected lifting of administrative restrictions.